open mobile menu

Accelerate Time To Market With A Proven Team of GI Experts

Tap into our extensive network of 5,000+ sites, leveraging exclusive data from central imaging projects in endoscopy and histopathology, and benefit from our team of medical and operational GI experts for swift study startup and accelerated patient recruitment.
In more than 60 countries
Supported 80% of approved GI drugs in the market
Unrivaled KOL network

Therapeutic Focus

Alimentiv stands at the forefront of patient recruitment and imaging innovations for gastrointestinal and liver diseases, driving health breakthroughs through advanced research, accelerated clinical trials, and delivering actionable biomarker insights. We are dedicated to redefining the future of GI and liver clinical research.

IBD
EGID/EoE
Celiac
Hepatology

Services

With over 30 years of pioneering advancements in gastrointestinal therapeutics, Alimentiv continues to advance clinical trials through medical research, development, and imaging solutions. Our team offers streamlined solutions for all stages of clinical development, from early Phase 1 to Phase 4 trials. We expertly address regulatory requirements, patient recruitment, protocol design, and data management, while our tailored approach minimizes costs and mitigates risks for your project’s success.

Clinical Trial Services
Medical Imaging Solutions
Precision Medicine
Medical Research & Development
Statistics
Real-World Evidence
Specialty Histopathology Lab
Spatial Biology

Latest Updates

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality...

Publication Jun 3, 2024
Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review
Article May 30, 2024
Alimentiv DDW 2024 Presentations

If you’ve missed some of our lecture presentations and poster sessions, reach out for more information....

See All Updates

Speak to a member
of our expert team

Contact us